Related Experiment Video

Updated: Jun 15, 2026

Preparation of Zinc Oxide Nanoparticles and the Evaluation of their Antibacterial Effects
06:42

Preparation of Zinc Oxide Nanoparticles and the Evaluation of their Antibacterial Effects

Published on: September 27, 2024

Use of nanoparticles as therapy for methicillin-resistant Staphylococcus aureus infections

Pei-Feng Liu1, Chih-Wei Lo, Chao-Hsuan Chen

  • 1Department of Medicine, University of California, San Diego, 92161, USA.

Current Drug Metabolism
|March 11, 2010
PubMed

Insights

Nanoparticle antibiotic delivery offers a promising strategy to combat difficult-to-treat staphylococcal infections, including methicillin-resistant Staphylococcus aureus, by enabling targeted and controlled drug release.

Area of Science:

  • Microbiology
  • Nanotechnology
  • Infectious Diseases

Background:

  • Staphylococcal infections, primarily caused by Staphylococcus aureus, present significant health challenges.
  • The rise of antibiotic-resistant strains, such as methicillin-resistant Staphylococcus aureus (MRSA), complicates treatment and increases risks.
  • Current treatment limitations necessitate novel therapeutic approaches for staphylococcal infections.

Purpose of the Study:

  • To review the potential of nanoparticle-based drug delivery systems for treating staphylococcal infections.
  • To highlight the advantages of nanoparticles in enhancing antibiotic efficacy and overcoming resistance.
  • To explore targeted antibiotic delivery strategies using nanotechnology.

Main Methods:

  • Literature review focusing on nanoparticle applications in antibiotic therapy.
  • Analysis of studies investigating nanoparticle-mediated delivery of antibiotics against staphylococci.
  • Examination of controlled and targeted release mechanisms of antibiotics via nanoparticles.

Main Results:

  • Nanoparticle delivery systems show potential for improved antibiotic efficacy against staphylococcal pathogens.
  • Targeted delivery can enhance drug concentration at infection sites and reduce systemic toxicity.
  • Controlled release from nanoparticles may decrease dosing frequency and improve patient compliance.

Conclusions:

  • Nanoparticle-mediated antibiotic delivery is a promising strategy for managing staphylococcal infections, including MRSA.
  • This approach offers potential solutions for overcoming antibiotic resistance and improving treatment outcomes.
  • Further research into nanoparticle formulations and targeted delivery is warranted for clinical application.

More Related Videos

Evaluation of Antimicrobial Activities of Nanoparticles and Nanostructured Surfaces In Vitro11:52

Evaluation of Antimicrobial Activities of Nanoparticles and Nanostructured Surfaces In Vitro

Published on: April 21, 2023

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus (MRSA) Infection07:32

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus (MRSA) Infection

Published on: September 1, 2023

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Microbial Corrosion01:24

Microbial Corrosion

Microbiologically Influenced Corrosion (MIC) is a significant form of material degradation caused by the metabolic activities of microorganisms. This phenomenon poses substantial challenges across various industries, including oil and gas, maritime, and water treatment sectors.MIC occurs when microorganisms, such as bacteria, archaea, and fungi, colonize metal surfaces, forming biofilms that alter the local electrochemical environment. These biofilms can lead to the production of corrosive...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...